Bristol-Myers Squibb | BMY

Stock Price
60.88
Daily Change
0.72 1.20%
Monthly
11.30%
Yearly
26.78%
Q3 Forecast
59.46

EPS Reference Time Actual Consensus Previous
2026-10-29 FY2026Q3 AM 1.60 1.63
2026-07-30 FY2026Q2 AM 1.61 1.46
2026-04-30 FY2026Q1 AM 1.58 1.45 1.80
2026-02-05 FY2025Q4 AM 1.26 1.61 1.67
2025-10-30 FY2025Q3 AM 1.63 1.69 1.80



Peers Price Chg Day Year Date
AbbVie 256.13 2.75 1.09% 36.89% Jul/21
Abbott 99.71 -1.95 -1.92% -20.70% Jul/21
ALKERMES 52.07 -0.65 -1.23% 78.20% Jul/20
Amgen 362.45 -1.72 -0.47% 18.57% Jul/21
AstraZeneca 12,492.00 112.00 0.90% 20.67% Jul/21
Biogen 202.74 2.79 1.40% 58.58% Jul/21
Bristol-Myers Squibb 60.88 0.72 1.20% 26.78% Jul/21
Coherus Biosciences 1.44 0.02 1.06% 55.59% Jul/21
Gilead Sciences 130.25 -2.96 -2.22% 18.23% Jul/21
GlaxoSmithKline 1,893.00 11.00 0.58% 40.48% Jul/21

Indexes Price Day Year Date
US500 7502 65.92 0.89% 17.98% Jul/22

Bristol-Myers Squibb traded at $60.88 this Tuesday July 21st, increasing $0.72 or 1.20 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb gained 11.30 percent. Over the last 12 months, its price rose by 26.78 percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at 59.46 by the end of this quarter and at 55.80 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.



News Stream
Bristol-Myers Squibb Stock Price Hits 6-week High
Bristol-Myers Squibb shares increased to 58.89 USD, the highest since May 2026. Over the past 4 weeks, Bristol-Myers Squibb gained 4.66%, and in the last 12 months, it increased 24.33%.
2026-07-13
Bristol-Myers Squibb Stock Price Hits 4-week High
Bristol-Myers Squibb shares increased to 57.85 USD, the highest since May 2026. Over the past 4 weeks, Bristol-Myers Squibb gained 0.56%, and in the last 12 months, it increased 24.79%.
2026-06-29
Bristol-Myers Squibb Stock Price Hits 21-week Low
Bristol-Myers Squibb shares decreased to 54.20 USD, the lowest since January 2026. Over the past 4 weeks, Bristol-Myers Squibb lost 5.36%, and in the last 12 months, it increased 15.8%.
2026-06-18